Blocking CXCL10 rescued PsA-like phenotypes (skin and joint inflammation), as indicated by attenuated epidermal hyperplasia, inflammatory infiltration, enthesitis, cartilage damage, and bone erosions (Figure 3, M–P, and Supplemental Figure 4, G-K). This evidence concerns the gene CXCL10 and Arthritis.